A randomised controlled trial of aetiology based antiemetic guidelines for reducing nausea in advanced cancer patients.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/614247

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Nausea is a problem that can be very distressing to patients, and one that is difficult to assess and manage in patients with advanced cancer due to its multiple potential causes for this group. This study aims to test the effectiveness of an intervention which uses available anti-nausea medication specifically targeted to the likely cause of nausea for that individual to reduce the severity and impact of the symptom. It also tests second line medicatioins where nausea is unrelieved.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2016

Funding Scheme: Project Grants

Funding Amount: $1,152,116.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Clinical Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

advanced cancer | clinical guidelines | nausea | palliative care | quality of life | randomised controlled trial | symptom reduction

Related Links